Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata and atopic dermatitis have similar healthcare costs, but alopecia areata leads to more outpatient and long-term disability expenses.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Chemical exposure may contribute to the rise in atopic diseases and needs more research.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Atopic dermatitis severity doesn't worsen during pregnancy for most women.

A baby was diagnosed with IFAP syndrome due to a new genetic mutation, showing severe skin and developmental issues.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

Understanding the skin's bacteria and chemicals may help manage scalp issues in atopic dermatitis.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

A mutation in the hairless gene speeds up severe itchy skin in mice on a special diet.

Filaggrin mutations are linked to atopic dermatitis and help explain how genetics and environment affect the disease.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Having asthma, atopic dermatitis, or Hashimoto's thyroiditis increases the risk of severe and long-lasting alopecia areata.

AD-derived keratinocytes effectively mimic inflammation in atopic dermatitis.

Children with atopic diseases have a higher risk of developing alopecia areata.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.